Dr. Cho is a graduate of Stanford University where he earned an M.S. in Materials Science and Engineering, and a Ph.D. in Chemical Engineering. During his doctoral studies, Dr. Cho first gained an interest in research at the interface of molecular virology and biomaterials. Dr. Cho then continued his postdoctoral training in the Division of Gastroenterology and Hepatology at the Stanford University School of Medicine. He applied these engineering technologies to combat the Hepatitis C virus (HCV), which affects over 150 million people worldwide. His work has led to significant advances for treating HCV, including new drugs currently in preclinical or clinical trials. In addition, Dr. Cho has pioneered a novel approach to liver tissue engineering that has enabled an improved artificial organ system for studying liver disease.